EVPL and atherosclerosis: Continuous delivery of a low-dose ApoB–peptide mix (p210, p240, and MDA-p210) without adjuvant over 2 weeks via subcutaneously implanted minipumps significantly reduced atherosclerosis in Apoe−/− mice through induction of a Treg response [127].